NTRK1 and neuroblastoma: In neuroblastoma patients, TrkA is initially gained and its overexpression is found mainly at lower stages and younger age at diagnosis [4]; in neuroblastoma cells instead, TrkA activation decreases proliferation via MAPK induction and induces anti-oncogenic response [46].